COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04359810


Column Value
Trial registration number NCT04359810
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

First author
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Max O'Donnell, MD

Contact
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

mo2130@cumc.columbia.edu

Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2020-04-24

Recruitment status
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Blind label

Center
Last imported at : Nov. 7, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

multi-center

Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

inclusion criteria: - willing and able to provide written informed consent prior to performing study procedures or have a legally authorized representative available to do so. - age ≥18 years - evidence of sars-cov-2 infection by pcr test of naso-/oro-pharyngeal swab or tracheal aspirate sample within 14 days of randomization - peripheral capillary oxygen saturation (spo2) ≤ 94% on room air or requiring supplemental oxygen, non-invasive or invasive mechanical ventilation at screening - evidence of infiltrates on chest radiography - females of childbearing age and males, must be willing to practice an effective contraceptive method or remain abstinent during the study period.

Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

participation in another clinical trial of anti-viral agent(s) for covid-19 receipt of any anti-viral agent(s) with possible activity against sars-cov-2 <24 hours prior to study drug administration [1] mechanically ventilated (including veno-venous (vv)-ecmo) ≥ 5 days severe multi-organ failure history of prior reactions to transfusion blood products meeting definitive case definition criteria, at least severe severity, and probable or definite imputability per national healthcare safety network (nhsn)/centers for disease control and prevention (cdc) criteria known immunoglobulin a (iga) deficiency females who are pregnant use of remdesivir as treatment for covid-19 is permitted.

Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Max O'Donnell

Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Countries
Last imported at : Nov. 7, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Brazil;United States

Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Severe disease at enrollment

Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

6: Severe disease at enrollment

Total sample size
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

223

primary outcome
Last imported at : Nov. 7, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Day 28 severity outcome

Notes
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov

Phase 2

Arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 322, "treatment_name": "Convalescent plasma", "treatment_type": "Convalescent plasma", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]